IQGAP1 control of centrosome function defines distinct variants of triple negative breast cancer

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Triple negative breast cancer (TNBC) is aggressive, lacking clear diagnostic markers and therapeutic targets.
• IQGAP1 is a signaling scaffold involved in TNBC, but its precise role remains unclear.

Purpose of the Study:

• To elucidate the mechanism of IQGAP1 in triple negative breast cancer.
• To identify potential therapeutic targets and classification methods for TNBC.

Main Methods:

• Investigated IQGAP1 localization and interactions with centrosome proteins, including BRCA1.
• Utilized genetic mutant analyses to study IQGAP1 phosphorylation cycling and its effect on BRCA1 shuttling.
• Analyzed TNBC cell lines and patient tissues to identify distinct molecular variants.

Main Results:

• IQGAP1 localizes to the centrosome and influences BRCA1 expression, localization, and centrosome number.
• IQGAP1 phosphorylation cycling is crucial for its localization and BRCA1 centrosome-nuclear transport, defining two proliferation mechanisms.
• Distinct TNBC variants exhibit differential IQGAP1-BRCA1 dynamics and a novel signaling pathway involving Erk1/2, MNK1, JNK, Akt, and β-catenin.

Conclusions:

• IQGAP1 modulates centrosome-nuclear crosstalk, impacting cell division and cancer progression.
• Findings reveal molecularly distinct TNBC variants and suggest IQGAP1 as a common target for personalized medicine.
• This research has implications for understanding cancer disparities and developing new TNBC classification tools.